Publicacións (67) Publicacións de Vanesa Balboa Barreiro

2024

  1. Metabolic syndrome is not associated with erosive hand osteoarthritis: a cross-sectional study using data from the PROCOAC cohort

    Scientific Reports, Vol. 14, Núm. 1

  2. Mitonuclear epistasis involving TP63 and haplogroup Uk: Risk of rapid progression of knee OA in patients from the OAI

    Osteoarthritis and Cartilage, Vol. 32, Núm. 5, pp. 526-534

  3. Prediction of bronchopulmonary dysplasia in very preterm infants: competitive risk model nomogram

    Frontiers in Pediatrics, Vol. 12

  4. Prognostic model to predict the incidence of radiographic knee osteoarthritis

    Annals of the Rheumatic Diseases, Vol. 83, Núm. 5, pp. 661-668

2023

  1. A meta-analysis and a functional study support the influence of mtDNA variant m.16519C on the risk of rapid progression of knee osteoarthritis

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 7, pp. 974-984

  2. Colorectal cancer recurrence and its impact on survival after curative surgery: An analysis based on multistate models

    Digestive and Liver Disease

  3. Epidemiología de la COVID-19 entre el personal de centros sanitarios y sociosanitarios del área sanitaria de A Coruña y Cee: (Pag.-e 101938)

    Semergen: revista española de medicina de familia, Núm. 5, pp. 2-2

  4. Identifying advanced MAFLD in a cohort of T2DM and clinical features

    Frontiers in Endocrinology, Vol. 14

  5. Parámetros dosimétricos en cateterismos para cardiopatías congénitas en España: registro multicéntrico Radcong-21 del GTH-SECPCC

    REC: Interventional Cardiology, Vol. 5, Núm. 4, pp. 254-262

  6. Podiatric Skin and Nail Involvement and Biomechanical Pathology in Renal Transplant Recipients: Assessment of the Foot as a Contributing Factor to Their Health

    Healthcare (Switzerland), Vol. 11, Núm. 23

  7. Postoperative Events in Incompatible Living Donor Kidney Transplant Recipients Undergoing Prior Desensitization

    Transplantation Proceedings, Vol. 55, Núm. 7, pp. 1575-1580

  8. Renal profile of patients treated with elvitegravir/ cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort

    European Journal of Hospital Pharmacy, Vol. 30, Núm. 4, pp. 221-226

2022

  1. Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago

    Dermatology and Therapy, Vol. 12, Núm. 3, pp. 761-770

  2. Discontinuation due to neuropsychiatric adverse events with efavirenz-and dolutegravir-based antiretroviral therapy: a comparative real-life study

    European Journal of Hospital Pharmacy, Vol. 29, Núm. 4, pp. 207-211

  3. Hombro doloroso postictus: Estudio epidemiológico y análisis asistencial en el área sanitaria de la coruña

    Fisioterapia, Vol. 44, Núm. 2, pp. 95-101

  4. Improving heat and moisture exchanger therapy with a hydrogel base adhesive in laryngectomized patients: An open randomized crossover trial

    Journal of Laryngology and Otology

  5. Listado de medicamentos a evitar en atención primaria y su aplicación en pacientes polimedicados

    Galicia Clínica, Vol. 83, Núm. 1, pp. 6-11

  6. Persistence and Waning of Natural SARS-CoV-2 Antibodies Over 18 Months: Long-Term Durability of IgG Humoral Response in Healthcare Workers

    Journal of General Internal Medicine

  7. Relationship between time from symptom's onset to diagnosis and prognosis in patients with symptomatic colorectal cancer

    BMC cancer, Vol. 22, Núm. 1, pp. 910

  8. Volume tumor impact on melanoma survival assessed using Breslow density

    Journal of the American Academy of Dermatology, Vol. 86, Núm. 6, pp. 1410-1412